Financials
- Market Capitalization 5.31 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-135.05
売上高対価格比率
5.18
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1276 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 101.28 USD | +2.68% | +5.73% | +22.75% | +428.33% | 5.54 B USD | ||
| 1286 | CELC Celcuity Inc. - Common Stock | 111.05 USD | +6.99% | -2.59% | +25.42% | +700.65% | 5.42 B USD | ||
| 1334 | DFTX Definium Therapeutics, Inc. - Common Shares | 45.98 USD | +5.34% | +2.47% | +94.42% | +204.30% | 5.01 B USD | ||
| 1361 | CRSP CRISPR Therapeutics AG - Common Shares | 50.46 USD | -0.34% | -13.80% | -4.25% | -5.58% | 4.87 B USD |